title: Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma.
abstract: Head and neck squamous cell carcinoma (HNSCC) is a major healthcare problem worldwide affecting more than half a million patients each year. Despite considerable advances in the treatment of HNSCC, a high rate of recurrences aggravates the clinical situation and disease outcomes have only modestly improved. Recent insights show that cancer is not only a disease of the transformed epithelium but is also influenced and dependent on its stromal environment. In this review we suggest that resident and bone marrow (BM)-derived mesenchymal stem cells (MSCs) are precursors of the stroma associated with HNSCC and contribute to blood- and lymph angiogenesis, modulate the immune system and produce tumor-associated myofibroblasts. In addition, the impact of radiation therapy on the stromal reaction in HNSCC is discussed. Understanding the mechanisms of how MSCs promote invasive growth and metastasis in HNSCC and respond to cancer management strategies is of profound medical importance and will help us to design improved therapeutic protocols.
authors.affiliation: Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium.
authors.forename: Astrid
authors.initials: A
authors.lastname: De Boeck
authors.forename: Kishan
authors.initials: K
authors.lastname: Narine
authors.forename: Wilfried
authors.initials: W
authors.lastname: De Neve
authors.forename: Marc
authors.initials: M
authors.lastname: Mareel
authors.forename: Marc
authors.initials: M
authors.lastname: Bracke
authors.forename: Olivier
authors.initials: O
authors.lastname: De Wever
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000532:radiotherapy / Q000556:secondary; D018450:Disease Progression; D005260:Female; D006258:Head and Neck Neoplasms / Q000473:pathology* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000528:radiation effects; D009361:Neoplasm Invasiveness / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000166:cytology* / Q000528:radiation effects; D009389:Neovascularization, Pathologic / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor